Immune Response News and Research

RSS

Study sheds light on how T cells specialize to combat pathogens

Scientists from the University of Basel have gained insights into the specialization of T cells.

11 Mar 2021

Targeted immunotherapy could improve radiotherapy response in cancer cells

Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with immunotherapy, a new study suggests.

9 Mar 2021

SARS-CoV-2 can make itself unrecognizable to immune response by T-killer cells through mutations

The body's immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the so-called T-killer cells, are also responsible for detecting viruses in the body and eliminating them.

5 Mar 2021

Study shows causal relationship between neonatal antibody production and mother's microbiota

A healthy system of gut bacteria, or microbiota, is crucial to health: Gut bacteria not only aid with digestion, but also play an important role in the body's immune response. Infants, however, are not born with full-fledged gut microbiota, which makes it difficult for them to fight off intestinal infections.

4 Mar 2021

Study shows how antibodies fight Zika virus

Zika outbreaks are still having lasting effects on children whose mothers were infected with the Zika virus during their pregnancy.

26 Feb 2021

Human monoclonal antibodies can act as biological substitute for chemical antibiotics

In the course of a new and groundbreaking study, led by Dr, Natalia Freund and the doctoral candidate Avia Waston at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal antibodies, which hindered the growth of tuberculosis germs in laboratory mice.

23 Feb 2021

Epigenetic therapy can boost the ability of immune killer T-cells to destroy cancer cells

Developing “super soldiers” of particular white blood cells to promote an anti-tumor reaction has been demonstrated in a series of well-designed experiments.

23 Feb 2021

Genes could help determine the intensity of neutralizing antibodies to COVID-19 virus

While neutralizing antibodies form in less than two weeks of a COVID-19 infection, their intensity and durability can differ from one individual to another.

22 Feb 2021

Study identifies how CTLA-4 blockade can disable suppressive immune cells to aid tumor destruction

A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors.

18 Feb 2021

Understanding the herbivory-sensing mechanism of plants through elicitors

Plants are known to possess solid immune response mechanisms. One such response is “sensing” attack by herbivorous animals.

From Tokyo University of Science 18 Feb 2021

Study suggests a way to improve immunotherapy by altering immune cells’ access to sugar

Cancer cells and immune cells share something in common: They both love sugar. Sugar is an important nutrient. All cells use sugar as a vital source of energy and building blocks. For immune cells, gobbling up sugar is a good thing, since it means getting enough nutrients to grow and divide for stronger immune responses. But cancer cells use sugar for more nefarious ends.

17 Feb 2021

Innovative system allows complete study of SARS-CoV-2 mutant spectrum by ultrasequencing

Researchers have designed a program that allows the complete study of the SARS-CoV-2 mutant spectrum by ultrasequencing.

15 Feb 2021

Animal model yields important insights into T cell exhaustion

T lymphocytes, or T cells, are an important component of our immune system. They can recognize foreign proteins, so-called antigens, as peptide fragments - for instance, those derived from viruses or cancer cells.

15 Feb 2021

Study reveals a new role of SRC-3 protein in various cancers

New research has revealed a new role of the steroid receptor coactivator 3, also called SRC-3/NCOA3.

15 Feb 2021

Seasonal human coronavirus antibodies not associated with protection against SARS-CoV-2

Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2, according to a study led by Scott Hensley, PhD, an associate professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania.

11 Feb 2021

Inherited genetic variation plays a role in how patients respond to cancer immunotherapy

For all their importance as a breakthrough treatment, the cancer immunotherapies known as checkpoint inhibitors still only benefit a small minority of patients, perhaps 15 percent across different types of cancer. Moreover, doctors cannot accurately predict which of their patients will respond.

11 Feb 2021

Mast Cells: High-speed messengers of the immune defense

In order to fight pathogens, mast cells regulate inflammatory reactions of the immune system.

10 Feb 2021

Study reveals genetic factors linked to COVID-19 susceptibility in people with Down syndrome

A study reveals the genetic factors that may expose or protect people with Down syndrome from SARS-CoV-2 infection, as well as the prognosis of COVID-19.

9 Feb 2021

Study suggests the need to characterize patient-specific responses to respiratory syncytial virus

Researchers at Baylor College of Medicine found that while most individuals responded to respiratory syncytial virus (RSV) natural reinfection with a typical sustained antibody response associated with protection, a few individuals surprisingly responded atypically, not being able to sustain the antibody response, which declined to levels that made the individuals susceptible to RSV reinfection.

5 Feb 2021

New technology could improve antibody testing in a broad range of diseases

A global team of researchers has developed a new strategy for fast and reliable antibody tests, which can quantify the immune response induced by vaccination and reveal the timeline and stage of pathogen infection.

5 Feb 2021

Immune Response News and Research

Study sheds light on how T cells specialize to combat pathogens

Targeted immunotherapy could improve radiotherapy response in cancer cells

SARS-CoV-2 can make itself unrecognizable to immune response by T-killer cells through mutations

Study shows causal relationship between neonatal antibody production and mother's microbiota

Study shows how antibodies fight Zika virus

Human monoclonal antibodies can act as biological substitute for chemical antibiotics

Epigenetic therapy can boost the ability of immune killer T-cells to destroy cancer cells

Genes could help determine the intensity of neutralizing antibodies to COVID-19 virus

Study identifies how CTLA-4 blockade can disable suppressive immune cells to aid tumor destruction

Understanding the herbivory-sensing mechanism of plants through elicitors

Study suggests a way to improve immunotherapy by altering immune cells’ access to sugar

Innovative system allows complete study of SARS-CoV-2 mutant spectrum by ultrasequencing

Animal model yields important insights into T cell exhaustion

Study reveals a new role of SRC-3 protein in various cancers

Seasonal human coronavirus antibodies not associated with protection against SARS-CoV-2

Inherited genetic variation plays a role in how patients respond to cancer immunotherapy

Mast Cells: High-speed messengers of the immune defense

Study reveals genetic factors linked to COVID-19 susceptibility in people with Down syndrome

Study suggests the need to characterize patient-specific responses to respiratory syncytial virus

New technology could improve antibody testing in a broad range of diseases

Analytical Chemistry - Industry Focus eBook eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics